VAUDREUIL-DORION, QC, Sept. 26 /CNW Telbec/ - As Immunotec looks to the
beginning of its twelfth year of operation, Co-founder, President and Chief
Executive Officer, Mr. C.H. (Chuck) Roberts announces his retirement from his
role as President. Mr. Roberts, a major shareholder in Immunotec, will
continue his involvement with the corporation, both as an active member of the
Board of Directors and as Co-founder, in a variety of public relations and
sales support roles.
Mr. Roberts' wealth of business acumen and experience in heading
successful Canadian companies, coupled with his sales vision for an
innovative, research-based product called Immunocal/HMS 90, were behind the
establishment of Immunotec Research Ltd. in 1996. His leadership and
entrepreneurial expertise took a post-retirement venture from its roots as a
small, Quebec-based enterprise to a major force within the North American
network marketing industry. With sales exceeding $36.9 million dollars
annually, Immunotec Inc. became a publicly-traded company in January 2007.
Mr. Roberts recognized that network marketing is about more than
industry-leading products; his unwavering commitment to Immunotec's thousands
of Distributors across Canada and the United States was the foundation for all
of his business decisions throughout his presidency. Now, with the company
firmly rooted, its longevity assured, and with an experienced and capable
corporate team in place, Mr. Roberts steps back from his operational role to
launch the company into its second phase, one of rapid expansion and growth.
The Board of Directors has approved the appointment of an incoming
President and CEO and will make the formal announcement early next week.
Immunotec operates out of a 37,000 square foot facility located in
Vaudreuil-Dorion, Quebec, Canada as well as a distribution centre located in
Swanton, Vermont, USA. Immunotec is engaged primarily in the development and
marketing of dietary supplements, food, vitamins, personal care products and
natural health products, many of which are manufactured on its behalf by third
parties. Immunotec's products are distributed and sold in Canada and the
United States through a network marketing system and in other countries under
exclusive distributorship agreements.
For further information:
For further information: Media contact: Richard Patte, Executive
Vice-President, (450) 510-4445, firstname.lastname@example.org